Metastatic Castration-Resistant Prostate Cancer
Also known as: Metastatic Castrate-resistant Prostate (CRPC) Cancer / Hormone-refractory prostate cancer metastatic / Metastatic Castration-Resistant Prostate Cancer (mCRPC) / Castrate Refractory Metastatic Prostate Cancer (mCRPC) / Castration resistant, metastatic Prostate Cancer / Metastatic Castration Resistant Prostate Cancer / Castration-resistant prostate cancer / Hormone-refractory prostate cancer / Hormone refractory prostate cancer (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB05812 | Abiraterone | An antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer. |
| DB06772 | Cabazitaxel | An antineoplastic agent used in combination with corticosteroids to treat metastatic castration-resistant prostate cancer in patients previously treated with a docetaxel-containing treatment regimen. |
| DB08899 | Enzalutamide | A second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer. |
| DB16778 | Lutetium Lu-177 vipivotide tetraxetan | A radioligand therapeutic agent used to treat prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer in adults. |
| DB11793 | Niraparib | A poly-ADP ribose polymerase inhibitor used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy. |
| DB09074 | Olaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. |
| DB00860 | Prednisolone | A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers. |
| DB00635 | Prednisone | A corticosteroid used to treat inflammation or immune-mediated reactions and to treat endocrine or neoplastic diseases. |
| DB08913 | Radium Ra 223 dichloride | A radiopharmaceutical agent used to treat patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease. |
| DB12332 | Rucaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat recurrent ovarian and prostate cancers in previously treated adults. |